Cargando…
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [(18)F]SiTATE
PURPOSE: Somatostatin analogues (SSA) are frequently used in the treatment of neuroendocrine tumours. Recently, [(18)F]SiTATE entered the field of somatostatin receptor (SSR) positron emission tomography (PET)/computed tomography (CT) imaging. The purpose of this study was to compare the SSR-express...
Autores principales: | Eschbach, Ralf S., Hofmann, Markus, Späth, Lukas, Sheikh, Gabriel T., Delker, Astrid, Lindner, Simon, Jurkschat, Klaus, Wängler, Carmen, Wängler, Björn, Schirrmacher, Ralf, Tiling, Reinhold, Brendel, Matthias, Wenter, Vera, Dekorsy, Franziska J., Zacherl, Mathias J., Todica, Andrei, Ilhan, Harun, Grawe, Freba, Cyran, Clemens C., Unterrainer, Marcus, Rübenthaler, Johannes, Knösel, Thomas, Paul, Tanja, Boeck, Stefan, Westphalen, Christoph Benedikt, Spitzweg, Christine, Auernhammer, Christoph J., Bartenstein, Peter, Unterrainer, Lena M., Beyer, Leonie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924143/ https://www.ncbi.nlm.nih.gov/pubmed/36793617 http://dx.doi.org/10.3389/fonc.2023.992316 |
Ejemplares similares
-
Dosimetry and optimal scan time of [(18)F]SiTATE-PET/CT in patients with neuroendocrine tumours
por: Beyer, Leonie, et al.
Publicado: (2021) -
Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [(18)F]SiTATE PET
por: Wängler, Carmen, et al.
Publicado: (2022) -
Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [(18)F]SiTATE
por: Unterrainer, Marcus, et al.
Publicado: (2023) -
Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [(18)F]SiTATE
por: Unterrainer, Marcus, et al.
Publicado: (2023) -
Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients
por: Ahmaddy, Freba, et al.
Publicado: (2020)